Baker Brothers Life Sciences Capital (GP), LLC Insider Trading
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is a 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and a 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and a Director in INCYTE CORP ($INCY) and a Director in NEUROGEN CORP ($NRGN) and a 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and a 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and a 10% Owner in VIROPHARMA INC ($VPHM) and a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and a 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and a Director in Ardea Biosciences, Inc./DE ($IBPI) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a Director in GENOMIC HEALTH INC ($GHDX) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Address: 667 MADISON AVENUE, 17TH FLOOR NEW YORK US 10021 NY
Companies in which Baker Brothers Life Sciences Capital (GP), LLC is an Insider
ADOLOR CORP
Trading Symbol: ADLRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 6,666,436 shares
Latest Transaction: Oct 29 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALLOS THERAPEUTICS INC
Trading Symbol: ALTHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 5,771,961 shares
Latest Transaction: Feb 06 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director, 10% Owner
Holdings: 4,036,097 shares
Latest Transaction: Jan 24 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Trading Symbol: AUXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 6,105,365 shares
Latest Transaction: Mar 31 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BIOCRYST PHARMACEUTICALS INC
Trading Symbol: BCRXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 3,831,534 shares
Current Value: $21,724,798
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOMIC HEALTH INC
Trading Symbol: GHDXIndustry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 5,674,104 shares
Current Value: $155,981,119
Latest Transaction: Mar 11 2011
$GHDX Market Capitalization: $928.37M
$GHDX Previous Close: $27.49
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
HERON THERAPEUTICS, INC. /DE/
Trading Symbol: HRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Apr 26 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 418,030 shares
Current Value: $652,127
Latest Transaction: Jul 30 2008
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INCYTE CORP
Trading Symbol: INCYIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 7,511,046 shares
Current Value: $887,655,416
Latest Transaction: Sep 23 2010
$INCY Market Capitalization: $23.12B
$INCY Previous Close: $118.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEUROGEN CORP
Trading Symbol: NRGNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 3,678,823 shares
Latest Transaction: Nov 13 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 13,470,692 shares
Current Value: $818,883,367
Latest Transaction: Feb 04 2011
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director
Holdings: 1,242,773 shares
Latest Transaction: Sep 30 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TAPESTRY PHARMACEUTICALS, INC
Trading Symbol: NPROIndustry: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Oct 17 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 9,080,664 shares
Latest Transaction: Apr 30 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 1,000.00 | 588,600 | 588,600,000 | 588,600 | |
Apr 26 2011 | HRTX | HERON THERAPEUTICS ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 0.04 | 294,300 | 11,772 | 294,300 | |
Feb 04 2011 | SGEN | SEATTLE GENETICS I ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 15.50 | 1,751,803 | 27,152,947 | 13,470,692 | 11.7 M to 13.5 M (+14.95 %) |
Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.56 | 20,000 | 511,150 | 5,674,104 | 5.7 M to 5.7 M (+0.35 %) |
Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.22 | 49,056 | 1,286,165 | 5,654,104 | 5.6 M to 5.7 M (+0.88 %) |
Mar 11 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.17 | 1,800 | 47,097 | 5,605,048 | 5.6 M to 5.6 M (+0.03 %) |
Mar 08 2011 | GHDX | GENOMIC HEALTH INC | Baker Brothers Life Sciences C ... | Director | Buy | P | 25.13 | 1,826 | 45,887 | 5,603,248 | 5.6 M to 5.6 M (+0.03 %) |
View all Baker Brothers Life Sciences Capital (GP), LLC insider transactions.